Bioprinting involves the use of 3D printing technology to build tissues and organs. Bioprinting precisely places cells, proteins, DNA, drug particles, growth factors and biologically active particles spatially to guide tissue generation and formation. It has been used extensively in the field of regenerative medicine.
A new automated process prints a peptide-based hydrogel scaffold containing uniformly distributed cells. The scaffolds hold their shapes well and successfully facilitate cell growth that lasts for weeks.
Fibrous proteins such as collagen and fibrinogen form a thin solid layer on the surface of an aqueous solution similar to the "skin" that forms on warm milk, according to a team of Penn State Researchers, who believe this finding could lead to more efficient bioprinting and tissue engineering.
MIT researchers have developed a simple, low-cost technology to administer powerful drug formulations that are too viscous to be injected using conventional medical syringes.
The life of each human being starts from a single cell, which subsequently divides to ultimately form into an embryo.
A research group led by Daniel Aili, associate professor at Linköping University, has developed a bioink to print tissue-mimicking material in 3D printers.
As we know, a malignant tumor is a complex system of mutated cells which constantly interacts with and involves healthy cells in the body.
Dr. Akhilesh K. Gaharwar, associate professor, has developed a highly printable bioink as a platform to generate anatomical-scale functional tissues. This study was recently published in the American Chemical Society's Applied Materials and Interfaces.
Researchers have 3D printed coral-inspired structures that are capable of growing dense populations of microscopic algae.